Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
about
Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical TrialsThe regulatory role of DPP4 in atherosclerotic disease.Cardiovascular effects of dipeptidyl peptidase-4 inhibitors.GLP-1 Agonists and Blood Pressure: A Review of the Evidence.Incretin-Based Therapy for Diabetes: What a Cardiologist Needs to Know.
P2860
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
@ast
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
@en
type
label
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
@ast
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
@en
prefLabel
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
@ast
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
@en
P2860
P356
P1433
P1476
Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
@en
P2093
Sanjay Rajagopalan
P2860
P304
P356
10.2217/CLP.14.59
P577
2015-01-01T00:00:00Z